Aging And Advancing Healthcare Will Expand Minimally Invasive Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
07 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$31.60
51.1% undervalued intrinsic discount16 Aug
US$15.46
1Y
11.5%7D
-1.4%